The atypical chemokine receptor CCRL2/ACKR5 as a new player in carcinogenesis and tumor progression

The atypical chemokine receptor CCRL2/ACKR5 as a new player in carcinogenesis and tumor progression

Responsabile Scientifico per UNIBS: Prof. Silvano Sozzani DMMT

Contributo AIRC: €  100.000,00 terza annualità

Bando:  Investigator Grant 2017

Torna su